MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillation.

MedTech veteran, Rich Ferrari, joins MedLumics’ Board of Directors as new Chairman.

Madrid, Spain, 10 February 2021  Read more…

MedLumics Proprietary Technology to be presented at 26th Annual International AF Symposium

MedLumics is developing a unique real-time, optically-guided ablation catheter to improve treatment of Atrial Fibrillation by RadioFrequency Ablation and Pulsed Field Ablation.

Presentation on Direct Lesion Assessment using Photonics during AF Ablation.

Madrid, Spain, 28 January 2021  Read more…